Skip to main content

RECURSION PHARMACEUTICALS, INC. insider trading

RXRXNASDAQ
$4.78+0.66 (+16.02% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-13.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • BBBlake BorgesonDirector1.1737%of company
  • DYDean Y. LiDirector0.6327%of company
  • NKNajat KhanCEO and President0.3951%of company
  • MSMichael SecoraChief Financial Officer0.2835%of company
  • BRBen R. TaylorChief Financial Officer0.2042%of company
  • DHDavid HallettChief Scientific Officer0.1989%of company
  • CGChristopher GibsonDirector0.1684%of company
  • TMTina Marriott LarsonPresident and COO0.0966%of company
  • ZDZavain DarDirector0.0468%of company
  • DJDavid J. MauroChief Medical Officer0.043%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
RXRXNajat KhanCEO and PresidentOpen market sell$78.8K-1.1%$3.52$78.8KSep 8, 2026Sep 10, 2026
RXRXBlake BorgesonDirectorOpen market sell$100K-0.5%$3.34$100KSep 1, 2026Sep 2, 2026
RXRXBlake BorgesonDirectorOpen market sell$97.5K-0.5%$3.25$97.5KAug 4, 2026Aug 6, 2026
RXRXBlake BorgesonDirectorOpen market sell$159K-0.6%$3.96$159KJul 7, 2026Jul 9, 2026
RXRXNamandje BumpusDirectorOpen market sell$12.6K-3.0%$3.18$12.6KJun 18, 2026Jun 22, 2026
RXRXNajat KhanCEO and PresidentOpen market sell$84.4K-1.1%$3.58$84.4KJun 5, 2026Jun 5, 2026
RXRXChristopher GibsonDirectorOpen market sell$145K-4.3%$3.62$145KJun 5, 2026Jun 5, 2026
RXRXNamandje BumpusDirectorOpen market sell$15.5K-9.2%$3.54$15.5KJun 3, 2026Jun 4, 2026
RXRXBlake BorgesonDirectorOpen market sell$110K-0.5%$3.68$110KJun 2, 2026Jun 4, 2026
RXRXChristopher GibsonDirectorOpen market sell$123K-4.3%$3.08$123KMay 22, 2026May 27, 2026
RXRXChristopher GibsonDirectorOpen market sell$135K-4.1%$3.37$135KMay 7, 2026May 8, 2026
RXRXBlake BorgesonDirectorOpen market sell$106K-0.5%$3.52$106KMay 5, 2026May 7, 2026
RXRXChristopher GibsonDirectorOpen market sell$144K-4.2%$3.61$144KApr 22, 2026Apr 24, 2026
RXRXChristopher GibsonDirectorOpen market sell$124K-4.2%$3.10$124KApr 7, 2026Apr 8, 2026
RXRXBlake BorgesonDirectorOpen market sell$93K-0.5%$3.10$93KApr 7, 2026Apr 8, 2026
RXRXChristopher GibsonDirectorOpen market sell$130K-4.2%$3.25$130KMar 23, 2026Mar 25, 2026
RXRXBen R. TaylorChief Financial OfficerOpen market sell$27K-0.7%$3.39$27KMar 17, 2026Mar 18, 2026
RXRXNajat KhanCEO and PresidentOpen market sell$94.8K-1.2%$3.35$94.8KMar 9, 2026Mar 11, 2026
RXRXBlake BorgesonDirectorOpen market sell$588K-2.6%$3.46$588KMar 3, 2026Mar 4, 2026
RXRXChristopher GibsonDirectorOpen market sell$138K-4.2%$3.46$138KFeb 19, 2026Feb 19, 2026
RXRXBen R. TaylorChief Financial OfficerOpen market sell$41.4K-1.1%$3.08$41.4KFeb 18, 2026Feb 19, 2026
RXRXChristopher GibsonDirectorOpen market sell$165K-4.2%$4.12$165KFeb 4, 2026Feb 6, 2026
RXRXBlake BorgesonDirectorOpen market sell$924K-3.3%$4.20$924KFeb 3, 2026Feb 6, 2026
RXRXChristopher GibsonDirectorOpen market sell$179K-4.2%$4.47$179KJan 20, 2026Jan 22, 2026
RXRXBlake BorgesonDirectorOpen market sell$959K-3.2%$4.36$959KJan 6, 2026Jan 8, 2026
RXRXChristopher GibsonDirectorOpen market sell$170K-4.1%$4.25$170KJan 5, 2026Jan 7, 2026
RXRXBen R. TaylorChief Financial OfficerOpen market sell$89.4K-2.7%$4.18$89.4KDec 29, 2025Dec 30, 2025
RXRXNajat KhanChief R&D Commercial OfficerOpen market sell$549K-16.9%$4.41$549KDec 22, 2025Dec 29, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$180K-4.2%$4.50$180KDec 19, 2025Dec 19, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$185K-4.1%$4.63$185KDec 4, 2025Dec 5, 2025
RXRXBlake BorgesonDirectorOpen market sell$961K-3.1%$4.37$961KDec 2, 2025Dec 4, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$166K-4.2%$4.16$166KNov 19, 2025Nov 19, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$208K-3.9%$5.21$208KNov 4, 2025Nov 6, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$570K-9.5%$5.70$570KOct 23, 2025Oct 24, 2025
RXRXChristopher GibsonChief Executive OfficerOpen market sell$604K-9.3%$6.04$604KOct 10, 2025Oct 10, 2025
End of history · 35 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.